Current Report Filing (8-k)
October 11 2017 - 4:26PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT
REPORT PURSUANT
TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date
of report (Date of earlit event reported): October 11, 2017
RENNOVA
HEALTH, INC.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
|
(State or Other Jurisdiction
of Incorporation)
|
001-35141
|
|
68-0370244
|
(Commission
File Number)
|
|
(I.R.S.
Employer
Identification No.)
|
400
S. Australian Avenue, Suite 800, West Palm Beach, Florida
|
|
33401
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
(561)
855-1626
(Registrant’s
Telephone Number, Including Area Code)
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item
5.02
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain
Officers.
|
Effective
October 11, 2017, our Board of Directors increased the size of our Board to six members and elected Gary L. Blum and John
Beach to fill the newly-created vacancies.
Mr.
Blum, 76, established the Law Offices of Gary L. Blum in 1986. Mr. Blum has served as counsel for a wide variety of closely-held
and public companies for over three decades. Prior to becoming an attorney, he was a tenured professor of philosophy at the University
of Nebraska, Omaha.
John
Beach, 55, has conceived and managed entrepreneurial ventures related to the healthcare industry for three decades. Most
recently, he was Chief Executive Officer of Accelerated Care Plus Corporation, the nation’s leading provider of
integrated clinical rehabilitation programs for post-acute rehabilitation providers, from 2000 through December 2012.
From December 2012 to March 2015, he was a private investor. He has been a director of Alana HealthCare, LLC, a post-acute
care provider, since March 2014 and served as Co-Chief Executive Officer from March 2015 through December 2016. Since 2010,
Mr. Beach has been the Chief Executive Officer of Next Steps LLC, which provides consulting services to
investment firms.
The
Board then made the following appointments to the three Standing Board
Committees.
Audit:
John Beach (Chairman)
Gary L. Blum
Dr. Kamran Ajami
Compensation:
Gary L. Blum (Chairman)
John Beach
Dr. Kamran Ajami
Nominating/Corporate
Governance:
Dr. Kamran Ajami (Chairman)
John Beach
Gary L. Blum
In addition to each being “independent,”
the Board of Directors determined that each of Mr. Blum and Mr. Beach is “financially literate” as required by the
Listing Rules of The Nasdaq Stock Market and that Mr. Beach qualifies as an “audit committee expert” as defined by
the rules and regulations of the Securities and Exchange Commission and meets the qualifications of “financial sophistication”
under the Listing Rules of The Nasdaq Stock Market. As a result of the above appointments, each Committee
is now made up of Mr. Blum, Mr. Beach and Dr. Ajami, three independent directors.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Date:
October 11, 2017
|
RENNOVA
HEALTH, INC.
|
|
|
|
|
By:
|
/s/
Seamus Lagan
|
|
|
Seamus
Lagan
|
|
|
Chief
Executive Officer
|
|
|
(principal
executive officer)
|